apomorphine has been researched along with sildenafil citrate in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (6.00) | 18.2507 |
2000's | 44 (88.00) | 29.6817 |
2010's | 3 (6.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Giuliano, F | 1 |
Andersson, KE; Chapman, TN; Gemalmaz, H; Steers, WD; Tuttle, JB; Waldeck, K | 1 |
Moncada Iribarren, I; Sáenz de Tejada, I | 1 |
Trummer, H | 1 |
Cowley, G | 1 |
Roumeguère, T | 1 |
Segraves, RT | 1 |
Mulhall, JP | 2 |
Giuliano, F; Padma-Nathan, H | 1 |
Porst, H | 1 |
Hatzichristou, DG; Pescatori, ES | 1 |
Anastasiadis, AG; Burchardt, M; Ghafar, MA; Shabsigh, R | 1 |
Castaneda, J; Castell, R; Hurley, D; Lammers, PI; Lipezker, M; Loehr, LA; Lowrey, F; Ponce de Leon, R; Rubio-Aurioles, E | 1 |
Köhn, FM | 1 |
O'Sullivan, JD | 1 |
Lenk, S | 1 |
Thomas, JA | 1 |
Anastasiadis, AG; Shabsigh, R | 1 |
Cestari, A; Deho', F; Guazzoni, G; Montorsi, F; Rigatti, P; Salonia, A; Stief, C | 1 |
Hauri, D; Müntener, M; Praz, V; Suter, S | 1 |
Tan, RS | 1 |
Erdei, E; Papp, G | 1 |
Steers, WD | 1 |
Schultheiss, D; Stief, CG | 1 |
Athanasopoulos, A; Barbalias, G; Chrysanthopoulou, A; Giannitsas, K; Gyftopoulos, K; Markou, SA; Perimenis, P; Tsota, I | 1 |
Briganti, A; Gallina, A; Montorsi, F; Rigatti, P; Salonia, A; Suardi, N | 1 |
Eardley, I; Edwards, A; Hole, J; MacDonagh, R; Wright, P | 1 |
Athanasopoulos, A; Barbalias, G; Giannitsas, K; Gyftopoulos, K; Liatsikos, E; Markou, S; Perimenis, P | 1 |
Kim, SW; Paick, JS; Park, JY; Son, H | 1 |
Basu, A; Ryder, RE | 1 |
Almasio, PL; Anello, G; Curto, F; Pavone, C; Pavone-Macaluso, M; Serretta, V | 1 |
Fontana, F; Frea, B; Gontero, P; Montorsi, F; Zitella, A | 1 |
Barbieri, L; Briganti, A; Chen, J; Dehò, F; Del Carro, U; Montorsi, F; Naspro, R; Rigatti, P; Rokkas, K; Salonia, A; Scattoni, V | 1 |
Kloner, RA; Reffelmann, T | 1 |
Hatzichristou, DG; Hatzimouratidis, K | 1 |
Hu, LQ; Hu, WL | 1 |
Xu, G; Xu, Y | 1 |
Dachille, G; Ludovico, GM; Pagliarulo, A; Pagliarulo, V; Ralph, D | 1 |
Gopalakrishanan, G; Tharyan, P | 1 |
Behre, HM; Burkart, M; Jungwirth, A; Porst, H | 1 |
Carson, CC | 1 |
Afif-Abdo, J; Cortado, P; Damião, R; Faria, G; Glina, S; Koff, W; Pompeo, AC; Sabaneeff, J; Teloken, C; Torres, LO; Wroclawski, E; Yamasaki, R | 1 |
Colpi, GM; Cormio, L; Giammusso, B; Guastella, B; Ludovico, G; Montorsi, F; Panzironi, C; Ponchietti, R; Soli, M | 1 |
Huang, X; Shen, J; Xiong, C; Zhou, J | 1 |
Elhenawee, M; Hashem, H; Ibrahim, AE | 1 |
Fan, Q; Jin, BF; Li, TF; Liu, T; Sun, ZX; Zhou, YC | 1 |
21 review(s) available for apomorphine and sildenafil citrate
Article | Year |
---|---|
[Treatment per os of disorders of erection].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Antidepressive Agents, Second-Generation; Apomorphine; Cyclic GMP; Dopamine Agonists; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Phentolamine; Piperazines; Purines; Sildenafil Citrate; Sulfones; Trazodone; Yohimbine | 1997 |
Pharmacological treatment of erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Muscle Relaxation; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 1999 |
[Oral therapy of erectile dysfunction].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Selective Serotonin Reuptake Inhibitors; Sildenafil Citrate; Sulfones; Trazodone; Yohimbine | 2000 |
New treatment for erectile dysfunction.
Topics: Apomorphine; Clinical Trials as Topic; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2000 |
Oral drug therapy for erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Apomorphine; Cardiovascular System; Contraindications; Coronary Disease; Cyclic Nucleotide Phosphodiesterases, Type 5; Dopamine Agonists; Erectile Dysfunction; Heart; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Prostatectomy; Purines; Sildenafil Citrate; Spinal Cord Injuries; Sulfones | 2001 |
Current treatments and emerging therapeutic approaches in male erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Erectile Dysfunction; Humans; Hypogonadism; Imidazoles; Male; Penile Implantation; Physical Therapy Modalities; Piperazines; Psychotherapy; Purines; Sildenafil Citrate; Sulfones; Testosterone; Triazines; Vacuum; Vardenafil Dihydrochloride; Vascular Surgical Procedures; Vasodilator Agents; Yohimbine | 2001 |
Economic aspects of medical erectile dysfunction therapies.
Topics: Apomorphine; Cost-Benefit Analysis; Dopamine Agonists; Erectile Dysfunction; Humans; Injections; Male; Penis; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Urethra | 2002 |
Pharmacological aspects of erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Apomorphine; Drug Interactions; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Trazodone | 2002 |
Erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Alprostadil; Apomorphine; Brain; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Penile Prosthesis; Penis; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2003 |
Pharmacological management of erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Carbolines; Drug Combinations; Erectile Dysfunction; Humans; Imidazoles; Injections; Male; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2003 |
[Erectile dysfunction: reasonable diagnostics and treatment in general practice].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Age Factors; Aged; Algorithms; Alprostadil; Apomorphine; Cohort Studies; Contraindications; Dopamine Agonists; Erectile Dysfunction; Family Practice; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Piperazines; Purines; Risk Factors; Sexual Partners; Sildenafil Citrate; Sulfones; Vasodilator Agents; Yohimbine | 2003 |
Novel treatment options for overlapping yet distinct erectile dysfunction and andropause syndromes.
Topics: Androgens; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone | 2003 |
[Conservative treatment of erectile dysfunction].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Imidazoles; Impotence, Vasculogenic; Injections; Male; Nitric Oxide; Papaverine; Phosphodiesterase Inhibitors; Piperazines; Psychotherapy; Purines; Sildenafil Citrate; Sulfones; Triazines; Vacuum; Vardenafil Dihydrochloride; Vasodilator Agents | 2003 |
Viability and safety of combination drug therapies for erectile dysfunction.
Topics: Alprostadil; Apomorphine; Dopamine Agonists; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2003 |
Oral drug treatment of erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Apomorphine; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2003 |
Emerging oral drugs for erectile dysfunction.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aged; Apomorphine; Carbolines; Comorbidity; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dopamine Agonists; Double-Blind Method; Drug Interactions; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Multicenter Studies as Topic; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Second Messenger Systems; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2004 |
New treatment options for erectile dysfunction in patients with diabetes mellitus.
Topics: Adult; Aged; Apomorphine; Diabetes Complications; Erectile Dysfunction; Half-Life; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Prevalence; Purines; Quality of Life; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones | 2004 |
Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
Topics: Administration, Oral; Apomorphine; Blood Pressure; Cardiovascular Diseases; Contraindications; Dopamine Agonists; Drug Interactions; Erectile Dysfunction; Humans; Hypotension; Male; Nitric Oxide Donors; Patient Selection; Phosphodiesterase Inhibitors; Piperazines; Purines; Risk Assessment; Sildenafil Citrate; Sulfones | 2005 |
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
Topics: Administration, Oral; Alprostadil; Apomorphine; Carbolines; Constriction; Contraindications; Dopamine Agonists; Drug Combinations; Enzyme Inhibitors; Erectile Dysfunction; Humans; Imidazoles; Male; Papaverine; Patient Satisfaction; Penile Prosthesis; Penis; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Regional Blood Flow; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Failure; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2005 |
[Pharmacotherapy for erectile dysfunction].
Topics: Animals; Apomorphine; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Sildenafil Citrate; Sulfones; Yohimbine | 2005 |
Erectile dysfunction.
Topics: Adult; Alprostadil; Apomorphine; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Penile Erection; Penile Prosthesis; Piperazines; Purines; Sex Counseling; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Yohimbine | 2006 |
10 trial(s) available for apomorphine and sildenafil citrate
Article | Year |
---|---|
Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hyd
Topics: Adrenergic alpha-Antagonists; Apomorphine; Cross-Over Studies; Double-Blind Method; Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Phentolamine; Piperazines; Purines; Safety; Severity of Illness Index; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents | 2002 |
A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction.
Topics: Apomorphine; Arteries; Cross-Over Studies; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Piperazines; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome; Vascular Diseases; Vasodilator Agents | 2004 |
An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Apomorphine; Cross-Over Studies; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents | 2004 |
Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study.
Topics: Apomorphine; Cross-Over Studies; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome | 2004 |
Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aged; Apomorphine; Cross-Over Studies; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Sildenafil Citrate; Sulfones | 2004 |
Comparison of the effect of sildenafil and apomorphine SL on nocturnal erections in healthy volunteers: a placebo-controlled study.
Topics: Adult; Analysis of Variance; Apomorphine; Humans; Male; Penile Erection; Piperazines; Prospective Studies; Purines; Sildenafil Citrate; Single-Blind Method; Sulfones | 2005 |
Sexual dysfunction in patients under dialytic treatment.
Topics: Adult; Aged; Apomorphine; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Renal Dialysis; Sildenafil Citrate; Sulfones | 2006 |
Comparative trial of treatment satisfaction, efficacy and tolerability of sildenafil versus apomorphine in erectile dysfunction--an open, randomized cross-over study with flexible dosing.
Topics: Adolescent; Adult; Aged; Apomorphine; Coitus; Cross-Over Studies; Erectile Dysfunction; Humans; Male; Middle Aged; Orgasm; Patient Satisfaction; Penile Erection; Piperazines; Purines; Sexual Partners; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Treatment Outcome | 2007 |
Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
Topics: Adult; Aged; Apomorphine; Coitus; Cross-Over Studies; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome | 2008 |
An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
Topics: Adult; Apomorphine; Cross-Over Studies; Dopamine; Erectile Dysfunction; Humans; Male; Middle Aged; Piperazines; Purines; Research Design; Safety; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Time Factors; Vasodilator Agents | 2008 |
19 other study(ies) available for apomorphine and sildenafil citrate
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of sildenafil on apomorphine-evoked increases in intracavernous pressure in the awake rat.
Topics: Animals; Apomorphine; Dopamine Agonists; Male; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Pressure; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones | 1999 |
Looking beyond Viagra. The 30 million American men with impotence problems may soon have two oral treatments to choose from. How do they compare?
Topics: Apomorphine; Erectile Dysfunction; Humans; Male; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2000 |
[Erectile dysfunction: an update on new therapeutic options].
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Aged; Apomorphine; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Nitric Oxide Donors; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2000 |
Current concepts in erectile dysfunction.
Topics: Administration, Oral; Adult; Aged; Algorithms; Apomorphine; Comorbidity; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Medical History Taking; Middle Aged; Penile Implantation; Phosphodiesterase Inhibitors; Physical Examination; Piperazines; Prostaglandins; Purines; Sildenafil Citrate; Sulfones; United States | 2000 |
Clinical perspective on erectile dysfunction therapies.
Topics: Adult; Aged; Apomorphine; Counseling; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Primary Health Care; Purines; Sexual Partners; Sildenafil Citrate; Sulfones | 2000 |
[Soon there will be potency pills for every need. What is the value of the new viagra competitors? (interview by Dr. Brigitte Moreano)].
Topics: Apomorphine; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome | 2001 |
[Erectile dysfunction. Help also for cardiac patients].
Topics: Apomorphine; Contraindications; Coronary Disease; Drug Interactions; Erectile Dysfunction; Humans; Male; Molsidomine; Nitrates; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2001 |
[Hypertension and impotence. Which potency drug is the most appropriate here?].
Topics: Antihypertensive Agents; Apomorphine; Clinical Trials as Topic; Dopamine Agonists; Drug Interactions; Erectile Dysfunction; Humans; Hypertension; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2002 |
Apomorphine as an alternative to sildenafil in Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Erectile Dysfunction; Humans; Injections, Subcutaneous; Male; Multiple System Atrophy; Parkinson Disease; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2002 |
[Progress in therapy of erectile dysfunction. New orally administered drugs].
Topics: Administration, Oral; Apomorphine; Clinical Trials as Topic; Erectile Dysfunction; Humans; Male; Phentolamine; Piperazines; Purines; Sildenafil Citrate; Sulfones; Trazodone; Treatment Outcome; Vasodilator Agents; Yohimbine | 2002 |
[Drug therapy of erectile dysfunction--the current status].
Topics: Administration, Oral; Administration, Topical; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Penis; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Vasodilator Agents; Yohimbine | 2003 |
Potentiation of apomorphine effect on sildenafil-induced penile erection in conscious rabbits.
Topics: Animals; Apomorphine; Blood Pressure; Consciousness; Drug Synergism; Male; Penile Erection; Piperazines; Purines; Rabbits; Sildenafil Citrate; Sulfones | 2004 |
A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy.
Topics: Administration, Sublingual; Aged; Algorithms; Apomorphine; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Patient Compliance; Penile Prosthesis; Piperazines; Postoperative Complications; Prospective Studies; Prostaglandins E; Prostatectomy; Prostatic Neoplasms; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome; Vacuum; Vasodilator Agents | 2005 |
[Determination of apomorphine, sildenafil and alprostadil in medicines for erectile dysfunction by high performance liquid chromatography-mass spectrometry].
Topics: Alprostadil; Apomorphine; Chromatography, High Pressure Liquid; Dopamine Agonists; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Male; Mass Spectrometry; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2005 |
Commentary on apomorphine versus sildenafil for erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome | 2008 |
Effect of sublingual medication of sildenafil citrate/ apomorphine on sexual behaviour of male rats.
Topics: Administration, Sublingual; Animals; Apomorphine; Drug Combinations; Female; Male; Models, Animal; Piperazines; Purines; Random Allocation; Rats; Rats, Sprague-Dawley; Sexual Behavior, Animal; Sildenafil Citrate; Sulfones | 2009 |
Chromatographic analysis of some drugs employed in erectile dysfunction therapy: qualitative and quantitative studies using calixarene stationary phase.
Topics: Apomorphine; Buffers; Calixarenes; Carbolines; Chromatography, High Pressure Liquid; Erectile Dysfunction; Humans; Hydrogen-Ion Concentration; Limit of Detection; Male; Pharmaceutical Preparations; Piperazines; Purines; Reproducibility of Results; Sildenafil Citrate; Sulfonamides; Tadalafil | 2014 |
[Therapeutic efficacy of Bushengzhuyang Fang (Yangjing Capsule) on phytoestrogen-induced erectile dysfunction: an experimental study].
Topics: Animals; Apomorphine; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Isoflavones; Luteinizing Hormone; Male; Penile Erection; Penis; Phytoestrogens; Phytotherapy; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfonamides; Testosterone; Vasodilator Agents | 2014 |